Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research | 2016-04-15 | PMID 26589432
Zumsteg Zachary S, Morse Natasha, Krigsfeld Gabriel and 10 more
